These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19804436)
1. Cost-effectiveness of 21 alternative cervical cancer screening strategies. Chuck A Value Health; 2010; 13(2):169-79. PubMed ID: 19804436 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland. Vassilakos P; Poncet A; Catarino R; Viviano M; Petignat P; Combescure C Gynecol Oncol; 2019 Apr; 153(1):92-99. PubMed ID: 30718124 [TBL] [Abstract][Full Text] [Related]
3. Benefits and costs of using HPV testing to screen for cervical cancer. Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of cervical cancer screening strategies based on the Papanicolaou smear test in Korea. Ko MJ; Kim J; Kim Y; Lee YJ; Hong SR; Lee JK Asian Pac J Cancer Prev; 2015; 16(6):2317-22. PubMed ID: 25824757 [TBL] [Abstract][Full Text] [Related]
5. Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program. Östensson E; Hellström AC; Hellman K; Gustavsson I; Gyllensten U; Wilander E; Zethraeus N; Andersson S Acta Obstet Gynecol Scand; 2013 Jul; 92(7):830-40. PubMed ID: 23530870 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. Kim JJ; Wright TC; Goldie SJ JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. van Rosmalen J; de Kok IM; van Ballegooijen M BJOG; 2012 May; 119(6):699-709. PubMed ID: 22251259 [TBL] [Abstract][Full Text] [Related]
8. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening. Tay SK; Lin LE; Goh RC Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890 [TBL] [Abstract][Full Text] [Related]
9. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Flores YN; Bishai DM; Lorincz A; Shah KV; Lazcano-Ponce E; Hernández M; Granados-García V; Pérez R; Salmerón J Cancer Causes Control; 2011 Feb; 22(2):261-72. PubMed ID: 21170578 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study. Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada. Vijayaraghavan A; Efrusy MB; Mayrand MH; Santas CC; Goggin P Can J Public Health; 2010; 101(3):220-5. PubMed ID: 20737813 [TBL] [Abstract][Full Text] [Related]
12. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa. Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment]. Zhao FH; Chen JF; Gao XH; Gao LM; Liu QG; Liu ZH; Xu H; Ma JF; Ma L; Xu XL; Hu SY; Ning Y; Shi JF; Qiao YL Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):632-6. PubMed ID: 23159002 [TBL] [Abstract][Full Text] [Related]
15. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. Mandelblatt JS; Lawrence WF; Gaffikin L; Limpahayom KK; Lumbiganon P; Warakamin S; King J; Yi B; Ringers P; Blumenthal PD J Natl Cancer Inst; 2002 Oct; 94(19):1469-83. PubMed ID: 12359856 [TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology. Termrungruanglert W; Khemapech N; Tantitamit T; Havanond P J Gynecol Oncol; 2019 Mar; 30(2):e17. PubMed ID: 30740950 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system. Chow IH; Tang CH; You SL; Liao CH; Chu TY; Chen CJ; Chen CA; Pwu RF Br J Cancer; 2010 Dec; 103(12):1773-82. PubMed ID: 21102588 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening. Vijayaraghavan A; Efrusy MB; Goodman KA; Santas CC; Huh WK Gynecol Oncol; 2010 Nov; 119(2):237-42. PubMed ID: 20713299 [TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta. Campos NG; Scarinci IC; Tucker L; Peral S; Li Y; Regan MC; Sy S; Castle PE; Kim JJ Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1114-1121. PubMed ID: 33771846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]